CA
NZ
UK
AU
IND
US
● Amaze Holdings removed CEO Aaron Day on August 3, 2026, with CFO Joel Krutz named interim CEO and Michael Pruitt elevated to chairman.
● Actelis Networks lifted grossMarginto 51% while growingRevenue20%, improving profitability metrics even as the company remains on OTC markets.
● BIO-key International halved its second-quarter loss compared to the prior year, a meaningful improvement in its path toward sustainability.
● FiscalNote Holdings published its PolicyNote MCP connector inside Anthropic's Claude on August 13, 2026, a significant distribution win.
● OMNIQ Corp points to a $170 billion border-security spending wave as a major addressable market opportunity for its machine-vision technology.
● TNL Mediagene formed a special committee to weigh a possibleMergerand asset sales, putting the company in play.
● Tenon Medical posted record second-quarter revenue, its strongest quarterly sales performance to date.
● Curis priced a $5.6 million raise carrying an explicit going-concern warning, underscoring the company's thin financial cushion.
● Eloxx Pharmaceuticals returned to trading on the Nasdaq Capital Market, less than three years after being removed from the exchange.
● Ernexa Therapeutics is lining up a third-quarter IND filing for lead candidate ERNA-101, its first application to test the drug in humans.
Please wait processing your request...